US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 19, 2018 (9 years ago)

Laroscorbine Platinum Vitamin C 1 gm Collagen 0.35 gm

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act.

What was recalled

Laroscorbine Platinum Vitamin C 1 gm Collagen 0.35 gm, Roche

Recalling firm
Flawless Beauty LLC
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0327-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Platinum recalls

See all
Class I · High risk Terminated

maXXzen Platinum 12000 capsule

Reason Marketed without an approved NDA/ANDA - Product found to be tainted with Sildenafil and Tadalafil.

Miracle 8989 D-0635-2021
Class I · High risk Terminated

PremierZEN Platinum 8000 capsule

Reason Marketed without an approved NDA/ANDA - Product found to be tainted with Sildenafil and Tadalafil.

Miracle 8989 D-0634-2021
Class I · High risk Terminated

Poseidon Platinum 3500 capsule

Reason Marketed Without An Approved NDA/ANDA: Product found to contain undeclared sildenafil and tadalafil making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.

Yamtun7 D-0654-2021
Class II · Moderate risk Ongoing

Imperial Platinum 2000

Reason Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.

QMart D-0371-2021
Class II · Moderate risk Ongoing

PremierZen Platinum 5000

Reason Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.

Na Na Collection D-0353-2021